1. Home
  2. CPSS vs IMUX Comparison

CPSS vs IMUX Comparison

Compare CPSS & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$8.91

Market Cap

204.6M

Sector

Finance

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$15.02

Market Cap

200.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
IMUX
Founded
1991
2016
Country
United States
United States
Employees
N/A
66
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
200.4M
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
CPSS
IMUX
Price
$8.91
$15.02
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$36.00
AVG Volume (30 Days)
25.2K
195.3K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
1.27
38.00
EPS
0.24
N/A
Revenue
$434,470,000.00
N/A
Revenue This Year
$147.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$40.08
N/A
Revenue Growth
10.41
N/A
52 Week Low
$6.67
$0.51
52 Week High
$10.49
$15.84

Technical Indicators

Market Signals
Indicator
CPSS
IMUX
Relative Strength Index (RSI) 42.03 61.45
Support Level $8.85 $0.74
Resistance Level $9.40 $15.81
Average True Range (ATR) 0.30 0.88
MACD -0.03 -0.13
Stochastic Oscillator 24.77 61.32

Price Performance

Historical Comparison
CPSS
IMUX

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: